[1] OOKA Y, MIHO K, SHUNTARO O, et al. Prediction of the very early occurrence of HCC right after DAA therapy for HCV infection[J]. Hepatol Int,2018,12(6):523-530. [2] LEE S, CHO Y Y, CHO E J, et al. Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERK[J]. Int J Mol Med,2018, 42(5):2551-2559. [3] LO J, LAU E Y, CHING R H, et al. Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice[J]. Hepatology,2015,62(2):534-545. [4] WEE S L, PEEK T, CLARKE A R. The responsiveness of Bactrocera jarvisi (Diptera:Tephritidae) to two naturally occurring phenylbutaonids, zingerone and raspberry ketone[J]. J Insect Physiol,2018,109:41-46. [5] CUI Y, SHI Y, BAO Y, et al. Zingerone attenuates diabetic nephropathy through inhibition of nicotinamide adenine dinucleotide phosphate oxidase 4[J]. Biomed Pharmacother, 2018,99:422-430. [6] KIM Y J, JEON Y, KIM T, et al. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells[J]. Bioorg Med Chem Lett, 2017,27(4):1081-1088. [7] RAOUL J L, KUDO M, FINN R S, et al. Systemic therapy for intermediate and advanced hepatocellular carcinoma:Sorafenib and beyond[J]. Cancer Treat Rev,2018,68:16-24. [8] CHOWDHURY S M, LEE T, BACHAWAL S V, et al. Longitudinal assessment of ultrasound-guided complementary microRNA therapy of hepatocellular carcinoma[J]. J Control Release,2018,281:19-28. [9] 乔宪伟, 王柯萌, 杨月娥. 索拉非尼对中晚期肝癌介入治疗患者生存率及不良反应的临床疗效分析[J]. 北方药学,2018,15(7):158. [10] URIARTE I, INSAUSTI A, COCINERO E J, et al. Competing dispersive interactions:From small energy differences to large structural effects in methyl jasmonate and zingerone[J]. J Phys Chem Lett,2018,9(20):5906-5914. [11] ERNST E, PITTLER M H. Efficacy of ginger for nausea and vomiting:a systematic review of randomized clinical trials[J]. Br J Anaesth,2000,84(3):367-371. [12] PALATTY P L, HANIADKA R, VALDER B,et al. Ginger in the prevention of nausea and vomiting:a review[J]. Crit Rev Food Sci Nutr,2013,53(7):659-669. [13] MIN G, KU S K, LEE T, et al. Suppressive effects of zingerone on TGFBIp-mediated septic responses[J]. Arch Pharm Res,2018,41(3):276-287. [14] KANDEMIR F M, YILDIRIM S, KUCUKLER S, et al. Therapeutic efficacy of zingerone against vancomycin-induced oxidative stress, inflammation, apoptosis and aquaporin 1 permeability in rat kidney[J]. Biomed Pharmacother,2018,105:981-991. [15] LEE J, OH S W, SHIN S W, et al. Zingerone protects keratinocyte stem cells from UVB-induced damage[J]. Chem Biol Interact,2018,279:27-33. [16] CHOI J S, RYU J, BAE W Y, et al. Zingerone suppresses tumor development through decreasing cyclin D1 expression and inducing mitotic arrest[J]. Int J Mol Sci,2018,19(9):E2832. [17] HE X X, SHI L L, QIU M J, et al. Molecularly targeted anti-cancer drugs inhibit the invasion and metastasis of hepatocellular carcinoma by regulating the expression of MMP and TIMP gene families[J]. Biochem Biophys Res Commun,2018,504(4):878-884. [18] 刘霞, 齐凤杰, 杜晓媛. 沉默CRAF基因表达对肝癌细胞侵袭和迁移的影响[J]. 吉林大学学报:医学版, 2018,44(3):521-525. [19] 杨安强, 杨晓滨, 李平,等. 脑膜瘤组织中CLDN6基因表达量与MMPs/TIMPs、EMT基因表达量的相关性研究[J]. 海南医学院学报,2017,23(17):2419-2422. [20] ZHOU M, LIU X J, LI Z H, et al. Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells[J]. Int J Cancer,2018,143(4):921-930. [21] 芮昆昆, 章波, 邰小华,等. 基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展[J]. 医学信息,2018, 31(3):21-24. [22] 李杰, 肖达, 李智奇. 基质金属蛋白酶9基因在肝癌细胞株、肝细胞肝癌组织中的表达及意义[J]. 中国卫生工程学,2018,17(3):351-353. [23] 陈小梦,闫昊,左子欣,等.癌组织中MMP-9的表达对食管癌诊断价值的meta分析[J].郑州大学学报:医学版,2018,53(5):642-647. [24] 陈薇,陈靖,游佳,等.MMP-9及glypican-3在肝癌组织中的表达及其临床病理价值[J].西安交通大学学报:医学版,2018,39(3):392-395. [25] STUELTEN C H, PARENT C A, MONTELL D J. Cell motility in cancer invasion and metastasis:insights from simple model organisms[J]. Nat Rev Cancer,2018,18(5):296-312. |